SE8803567L - Rekombinantisk, syntesen av maenniskofibroblast-beta-interferon kodande p lasmid-dnappr-ifn beta -13, foerfarande foer konstryering av naemnda plasmid-dna och maennisko-beta 1-interferon-producerande, naemnda plasmid-dna innehaallande bakteriestam av arten escherichia coli vniigenetika v1 903 (ppr-ifnbeta-13) - Google Patents

Rekombinantisk, syntesen av maenniskofibroblast-beta-interferon kodande p lasmid-dnappr-ifn beta -13, foerfarande foer konstryering av naemnda plasmid-dna och maennisko-beta 1-interferon-producerande, naemnda plasmid-dna innehaallande bakteriestam av arten escherichia coli vniigenetika v1 903 (ppr-ifnbeta-13)

Info

Publication number
SE8803567L
SE8803567L SE8803567A SE8803567A SE8803567L SE 8803567 L SE8803567 L SE 8803567L SE 8803567 A SE8803567 A SE 8803567A SE 8803567 A SE8803567 A SE 8803567A SE 8803567 L SE8803567 L SE 8803567L
Authority
SE
Sweden
Prior art keywords
ppr
plasmid
beta
construction
size
Prior art date
Application number
SE8803567A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8803567D0 (sv
Inventor
V G Debabov
Original Assignee
Vnii Genetiki Selek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vnii Genetiki Selek filed Critical Vnii Genetiki Selek
Publication of SE8803567L publication Critical patent/SE8803567L/
Publication of SE8803567D0 publication Critical patent/SE8803567D0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/565IFN-beta

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE8803567A 1987-02-09 1988-10-07 Rekombinantisk, syntesen av maenniskofibroblast-beta1-interferon kodande plasmid-dnappr-ifnbeta-13, foerfarande foer konstruering av naemnda plasmid-dna och maennisko-beta1-interferon-producerande, naemnda plasmid-dna innehaallande bakteriestam av arten escherichia coli vniigenetika vl 903 (ppr-ifnbeta-13) SE8803567D0 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU874191345A SU1703692A1 (ru) 1987-02-09 1987-02-09 Рекомбинантна плазмидна ДНК @ -1 @ 1-13, кодирующа синтез фибробластного интерферона ( @ I) человека, способ ее конструировани , штамм бактерий ЕSснеRIснIа coLI - продуцент @ I-интерферона человека

Publications (2)

Publication Number Publication Date
SE8803567L true SE8803567L (sv) 1988-10-07
SE8803567D0 SE8803567D0 (sv) 1988-10-07

Family

ID=21284355

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8803567A SE8803567D0 (sv) 1987-02-09 1988-10-07 Rekombinantisk, syntesen av maenniskofibroblast-beta1-interferon kodande plasmid-dnappr-ifnbeta-13, foerfarande foer konstruering av naemnda plasmid-dna och maennisko-beta1-interferon-producerande, naemnda plasmid-dna innehaallande bakteriestam av arten escherichia coli vniigenetika vl 903 (ppr-ifnbeta-13)

Country Status (9)

Country Link
JP (1) JPH01502478A (fi)
CH (1) CH676996A5 (fi)
FI (1) FI884556A (fi)
GB (1) GB2208866A (fi)
HU (1) HUT50871A (fi)
NL (1) NL8820103A (fi)
SE (1) SE8803567D0 (fi)
SU (1) SU1703692A1 (fi)
WO (1) WO1988005819A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0593792B2 (en) * 1992-10-14 2004-01-07 Ajinomoto Co., Inc. Novel L-threonine-producing microbacteria and a method for the production of L-threonine
ATE501168T1 (de) * 2004-12-20 2011-03-15 Cadila Healthcare Ltd Verfahren zur herstellung von hohen niveaus von interferon-beta

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582800A (en) * 1982-07-12 1986-04-15 Hoffmann-La Roche Inc. Novel vectors and method for controlling interferon expression

Also Published As

Publication number Publication date
FI884556A0 (fi) 1988-10-04
FI884556A (fi) 1988-10-04
NL8820103A (nl) 1989-01-02
GB2208866A (en) 1989-04-19
WO1988005819A1 (en) 1988-08-11
JPH01502478A (ja) 1989-08-31
HUT50871A (en) 1990-03-28
SE8803567D0 (sv) 1988-10-07
CH676996A5 (fi) 1991-03-28
SU1703692A1 (ru) 1992-01-07
GB8823728D0 (en) 1988-12-07

Similar Documents

Publication Publication Date Title
EP0028033A3 (en) Novel dna, cloned dna, recombinant plasmid containing the dna, microorganism containing the recombinant plasmid and process for their production
EP0431541A3 (en) Toxoplasma gondii antigen, its production and use
IL83192A0 (en) Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies
AR242634A1 (es) Transformante de escherichia coli y metodo para la produccion de etanol por medio del mismo.
AU580973B2 (en) Novel polypeptides with an ``-amylase-inhibiting action, a process for their preparation, their use and pharmaceutical products
AU6733487A (en) Mammalian interleukin-4
CA2116774A1 (en) Expression in e. coli antibody fragments having at least a cysteine present as a free thiol. use for the production of bifunctional f(ab') 2 antibodies
EP0307480A4 (en) PROCESS FOR THE PREPARATION OF AN ANTIBODY COMPLEX.
AU1347688A (en) Viral antigen, process for its production, and application in diagnosis and therapy (vaccine)
IL61041A0 (en) Dna transfer vectors and sequences for human proinsulin and preproinsulin,microorganisms prepared therewith and methods for the preparation and use thereof
AU2043488A (en) 1-phenyl-3-(1-piperazinyl)-1h-indazoles, a process and intermediates for their preparation, and the use thereof as medicaments
SE8803567L (sv) Rekombinantisk, syntesen av maenniskofibroblast-beta-interferon kodande p lasmid-dnappr-ifn beta -13, foerfarande foer konstryering av naemnda plasmid-dna och maennisko-beta 1-interferon-producerande, naemnda plasmid-dna innehaallande bakteriestam av arten escherichia coli vniigenetika v1 903 (ppr-ifnbeta-13)
AU1987088A (en) A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
FI102544B1 (fi) Menetelmä E.coli-kannan valmistamiseksi
NO180181C (no) Fremgangsmåte for fremstilling av et is-kjernedannende protein, plasmider og bakteriestammer
EP0293079A3 (en) Chlamydia vaccine
AU1887988A (en) Monoclonal antibodies against e7 protein of human type 16 papillomavirus, a process for their preparation, and their use
EP0156278A3 (en) Process for the preparation of symmetrical benzophenones substituted by fluor-containing groups, their use and symmetrical benzophenones substituted by fluor-containing groups
AU1321988A (en) The cloning of malaria-specific dna sequences: isolation of the gene for the 140 kd protein
SE8803566L (sv) Rekombinantisk, maenniskointerleukin-2-syntesen kodande plasmid-dna av ppr-il2-19-typ, foerfarande foer konstruering av denna plasmid-dna och maenniskointerleukin-2-producerande, naemnda plasmid-dna innehaallande bakteriestam av kulturen escherichia coli vniigenetika vl 903 (ppr-il2-19)
AU599133B2 (en) Novel substituted (4.2.0.)bicyclooctane derivatives with valuable therapeutic properties
SE8403929L (sv) Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
AU2484488A (en) Method for the production of antigenic protein-hapten conjugates, and antibodies corresponding thereto
NZ214428A (en) Preparation of e.coli antigens by recombinant dna methods
Molina et al. The role of Escherichia coli as recipient in the early stages of conjugation.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8803567-0

Effective date: 19920901